Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients

26 Aug 2022

Abstract excerpt

Intraductal papillary mucinous neoplasm (IPMN) is a common pancreatic precancerous lesion, with increasing incidence in recent years. However, the mechanisms of IPMN progression into invasive cancer remain unclear. The mRNA expression data of IPMN/PAAD patients were extracted from the TCGA and GEO databases. First, based on GSE19650, we analyzed the molecular alterations, tumor stemness, immune landscape, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36090038
DOI: 10.3389/fmolb.2022.887887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patientsPMID 36090038Read ↗

Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Semantic proximity Read ↗

Molecular Pathway and Immune Profile Analysis of IPMN-Derived versus PanIN-Derived Pancreatic Ductal AdenocarcinomasSemantic proximity Read ↗

Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.Semantic proximity Read ↗

A blood-based signature of cytoskeletal and extracellular remodeling for risk stratification of intraductal papillary mucinous neoplasmsSemantic proximity Read ↗

Identification of a novel immune-related gene prognostic index in pancreatic adenocarcinoma and its implication on tumor immunologySemantic proximity Read ↗

Evolution of the Spatial transcriptomic landscape during the progression of high-grade pancreatic intraductal papillary mucinous neoplasms to invasive cancerSemantic proximity Read ↗

A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor MicroenvironmentSemantic proximity Read ↗

An Accurate Prognostic Model and Treatment for Pancreatic Carcinoma Based on the Tumor Immune MicroenvironmentSemantic proximity Read ↗

Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancerSemantic proximity Read ↗

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic CancerSemantic proximity Read ↗

Transcriptomic dissection of Intraepithelial Papillary Mucinous Neoplasms progression by spatial technologies identified novel markers of pancreatic carcinogenesisSemantic proximity Read ↗

Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.